Presentation of a Novel Model for Evaluation of Commercialization of Research and Development: Case Study of the Pharmaceutical Biotechnology Industry
| Author | Hassan Emami | en |
| Author | Reza Radfar | en |
| Issued Date | 2017-07-31 | en |
| Abstract | The current situation in Iran suggests an appropriate basis for developing biotechnology industries, because the patents for the majority of hi-tech medicines registered in developed countries are ending. Biosimilar and technology-oriented companies which do not have patents will have the opportunity to enter the biosimilar market and move toward innovative initiatives. The present research proposed a model by which one can evaluate commercialization of achievements obtained from research with a focus on the pharmaceutical biotechnology industry. This is a descriptive-analytic study where mixed methodology is followed by a heuristic approach. The statistical population was pharmaceutical biotechnology experts at universities and research centers in Iran. Structural equations were employed in this research. | en |
| DOI | https://doi.org/10.22037/ijpr.2017.2068 | en |
| Keyword | Evaluation | en |
| Keyword | Commercialization indices | en |
| Keyword | Research and development pharmaceutical biotechnology | en |
| Publisher | Brieflands | en |
| Title | Presentation of a Novel Model for Evaluation of Commercialization of Research and Development: Case Study of the Pharmaceutical Biotechnology Industry | en |
| Type | Original Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijpr-16-1214.pdf
- Size:
- 529.25 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF